Cargando…
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression
BACKGROUND: Intraductal papillary mucinous neoplasm (IPMN) is the most common cystic preneoplastic lesion of pancreatic cancer. We used an approach coupling high resolution cytogenetic analysis (Affymetrix Oncoscan FFPE Array) with clinically-oriented bioinformatic interpretation of data to understa...
Autores principales: | Durante, Sandra, Vecchiarelli, Silvia, Astolfi, Annalisa, Grassi, Elisa, Casadei, Riccardo, Santini, Donatella, Panzacchi, Riccardo, Ricci, Claudio, Serravalle, Salvatore, Tarantino, Giuseppe, Falconi, Mirella, Teti, Gabriella, Indio, Valentina, Pession, Andrea, Minni, Francesco, Biasco, Guido, Di Marco, Mariacristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342702/ https://www.ncbi.nlm.nih.gov/pubmed/27566563 http://dx.doi.org/10.18632/oncotarget.11501 |
Ejemplares similares
-
External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model
por: Casadei, Riccardo, et al.
Publicado: (2021) -
Preoperative Gemcitabine and Oxaliplatin in a Patient with Ovarian Metastasis from Pancreatic Cystadenocarcinoma
por: Di Marco, Mariacristina, et al.
Publicado: (2012) -
CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
por: Tobaly, David, et al.
Publicado: (2020) -
Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications
por: Baiocchi, Gian Luca, et al.
Publicado: (2010) -
Total Pancreatectomy for Malignant Intraductal Papillary Mucinous Neoplasm (IPMN) Complicated by Gastropancreatic Fistulae
por: Basnayake, Oshan, et al.
Publicado: (2020)